Breast cancer index testing 81518.

Ended Purchase Order Awarded Last action

Contract number
HT001424P0252
Awardee
Awarding agency
Obligated
$139,428

Award facts

Contract value 100% obligated
$139,428.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20889, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The U.S. Defense Health Agency (DHA) has awarded a $139,428 firm fixed price purchase order to Biotheranostics Inc., a self-certified small disadvantaged business, to provide Breast Cancer Index testing services. This award, with a completion date of September 25, 2024, is not set aside and supports the DHA's efforts to enhance cancer care for veterans and service members through advanced molecular diagnostics that guide treatment planning. Biotheranostics, a division of Hologic, Inc., has secured multiple prime federal contracts with the Department of Veterans Affairs and DHA in recent years to deliver its specialized cancer testing services, totaling over $700,000 between 2021-2023.

Quick answers

Who was awarded contract HT001424P0252?

HT001424P0252 was awarded to Biotheranostics Inc. by Defense Health Agency (Department of Defense) on September 20, 2024.

How much is contract HT001424P0252 worth?

The government has obligated $139,428 on HT001424P0252.

Was contract HT001424P0252 competed?

The extent of competition for HT001424P0252 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login